Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease

Cited by (1,087)

Items 801–900 of 1,087

1. Enhancer variants associated with Alzheimer’s disease affect gene expression via chromatin looping
   Kikuchi, Masataka, Hara, Norikazu, Hasegawa, Mai, Miyashita, Akinori, Kuwano, Ryozo, Ikeuchi, Takeshi, Nakaya, Akihiro · 2019 · BMC Medical Genomics
2. A biologically-informed polygenic score identifies endophenotypes and clinical conditions associated with the insulin receptor function on specific brain regions
   Shantala A. Hari Dass, Kathryn McCracken, Irina Pokhvisneva, Lawrence M. Chen, Elika Garg, Thao T. T. Nguyen, Zihan Wang, Bárbara Barth, Moein Yaqubi, Lisa M. McEwen et al. · 2019 · EBioMedicine
3. Protective and Regenerative Roles of T Cells in Central Nervous System Disorders
   Frances Evans, Marie Dittmer, Alerie Guzman de la Fuente, Denise C. Fitzgerald · 2019 · Frontiers in Immunology
4. Identification of rare and common regulatory variants in pluripotent cells using population-scale transcriptomics
   Marc Jan Bonder, Craig Smail, Michael J. Gloudemans, Laure Frésard, David A. Jakubosky, Matteo D’Antonio, Xin Li, Nicole M. Ferraro, Ivan Carcamo‐Orive, Bogdan Andrei Mirauta et al. · 2021 · Nature Genetics
5. Open chromatin profiling of human postmortem brain infers functional roles for non-coding schizophrenia loci
   John F. Fullard, Claudia Giambartolomei, Mads E. Hauberg, Ke Xu, Georgios Voloudakis, Zhiping Shao, Christopher Bare, Joel T. Dudley, Manuel Mattheisen, Nikolaos K. R K Robakis et al. · 2017 · Human Molecular Genetics
6. <i>BDNF</i>Val66Met moderates memory impairment, hippocampal function and tau in preclinical autosomal dominant Alzheimer’s disease
   Lim, Yen Ying, Hassenstab, Jason, Cruchaga, Carlos, Goate, Alison, Fagan, Anne M., Benzinger, Tammie L. S., Maruff, Paul, Snyder, Peter J., Masters, Colin L., Allegri, Ricardo et al. · 2016 · Brain
7. Metabolic profiling distinguishes three subtypes of Alzheimer's disease
   Bredesen, Dale E. · 2015 · Aging
8. 2014 Report on the Milestones for the US National Plan to Address Alzheimer's Disease
   Keith N. Fargo, Paul S. S Aisen, Marilyn Albert, Rhoda Au, María M. Corrada, Steven Trent DeKosky, David A. Drachman, Howard M. Fillit, Laura N. Gitlin, Magali Haas et al. · 2014 · Alzheimer s & Dementia
9. Mineral Nutrition and the Risk of Chronic Diseases: A Mendelian Randomization Study
   Wenwen Cheng, Qiang Zhu, Hongyu Zhang · 2019 · Nutrients
10. Alternative splicing in Alzheimer’s disease
    Giuseppe Biamonti, Angela M. Amato, Elisa Belloni, Anna Di Matteo, Lucia Infantino, Davide Pradella, Claudia Ghigna · 2019 · Aging Clinical and Experimental Research
11. Genetic Markers of Alzheimer’s Disease
    Matea Nikolac Perković, Nela Pivac · 2019 · Advances in experimental medicine and biology
12. Type-2 diabetes and risk of dementia: observational and Mendelian randomisation studies in 1 million individuals
    Jesper Qvist Thomassen, Janne Schurmann Tolstrup, Marianne Benn, Ruth Frikke‐Schmidt · 2020 · Epidemiology and Psychiatric Sciences
13. Small RNA modifications in Alzheimer's disease
    Xudong Zhang, Fatima Trebak, Lucas A. C. Souza, Junchao Shi, Tong Zhou, Patrick G. Kehoe, Qi Chen, Yumei Feng · 2020 · Neurobiology of Disease
14. Maturation of neuronal AD-tau pathology involves site-specific phosphorylation of cytoplasmic and synaptic tau preceding conformational change and fibril formation
    Luis Aragão Gomes, Valerie Uytterhoeven, Diego Lopez-Sanmartin, Sandra O. Tomé, Thomas Tousseyn, Rik R. Vandenberghe, Mathieu Vandenbulcke, Christine A. F. Von Arnim, Patrik Verstreken, Dietmar Rudolf Thal · 2021 · Acta Neuropathologica
15. The concept of resilience to Alzheimer’s Disease: current definitions and cellular and molecular mechanisms
    L. D. de Vries, I. Huitinga, Helmut W. Kessels, D. Swaab, J. Verhaagen · 2024 · Molecular Neurodegeneration
16. Classifying Alzheimer's disease with brain imaging and genetic data using a neural network framework
    Kaida Ning, Bo Chen, Fengzhu Sun, Zachary B. Hobel, Lu Zhao, William J. Matloff, Arthur W. Toga · 2018 · Neurobiology of Aging
17. TREM2 regulates innate immunity in Alzheimer’s disease
    Li, Jiang-Tao, Zhang, Ying · 2018 · Journal of Neuroinflammation
18. Genome-wide, high-content siRNA screening identifies the Alzheimer’s genetic risk factor FERMT2 as a major modulator of APP metabolism
    ADGC, Alzheimer’s Disease Neuroimaging Initiative, Chapuis, Julien, Flaig, Amandine, Grenier-Boley, Benjamin, Eysert, Fanny, Pottiez, Virginie, Deloison, Gaspard, Vandeputte, Alexandre, Ayral, Anne-Marie, Mendes, Tiago et al. · 2017 · Acta Neuropathologica
19. Shared genetic contribution to ischemic stroke and Alzheimer's disease
    Traylor, Matthew, Adib‐Samii, Poneh, Harold, Denise, the Alzheimer's Disease Neuroimaging Initiative, The International Stroke Genetics Consortium (ISGC), UK Young Lacunar Stroke DNA resource, Dichgans, Martin, Williams, Julie, Lewis, Cathryn M., Markus, Hugh S., and the METASTROKE and International Genomics of Alzheimer's Project (IGAP) investigators · 2016 · Annals of Neurology
20. PICALM Rescues Endocytic Defects Caused by the Alzheimer’s Disease Risk Factor APOE4
    Narayan, Priyanka, Sienski, Grzegorz, Bonner, Julia M., Lin, Yuan-Ta, Seo, Jinsoo, Baru, Valeriya, Haque, Aftabul, Milo, Blerta, Akay, Leyla A., Graziosi, Agnese et al. · 2020 · Cell Reports
21. Increased PCSK9 cerebrospinal fluid concentrations in Alzheimer’s disease
    Zimetti, Francesca, Caffarra, Paolo, Ronda, Nicoletta, Favari, Elda, Adorni, Maria Pia, Zanotti, Ilaria, Bernini, Franco, Barocco, Federica, Spallazzi, Marco, Galimberti, Daniela et al. · 2016 · Journal of Alzheimer's Disease
22. The physical approximation of APP and BACE‐1: A key event in alzheimer's disease pathogenesis
    Jichao Sun, Subhojit Roy · 2017 · Developmental Neurobiology
23. FUN-LDA: A Latent Dirichlet Allocation Model for Predicting Tissue-Specific Functional Effects of Noncoding Variation: Methods and Applications
    Daniel Backenroth, Zihuai He, Krzysztof Kiryluk, Valentina Boeva, Lynn Petukhova, Ekta Khurana, Angela M. Christiano, Joseph D. Buxbaum, Iuliana Ionita‐Laza · 2018 · The American Journal of Human Genetics
24. Opportunities and challenges for the use of induced pluripotent stem cells in modelling neurodegenerative disease
    Yi‐Ying Wu, Feng‐Lan Chiu, Chan-Shien Yeh, Hung‐Chih Kuo · 2019 · Open Biology
25. Prognosis prediction model for conversion from mild cognitive impairment to Alzheimer’s disease created by integrative analysis of multi-omics data
    Daichi Shigemizu, Shintaro Akiyama, Sayuri Higaki, Taiki Sugimoto, Takashi Sakurai, Keith A. Boroevich, Alok K. Sharma, Tatsuhiko Tsunoda, Takahiro Ochiya, Shumpei Niida et al. · 2020 · Alzheimer s Research & Therapy
26. Genetic variation within endolysosomal system is associated with late-onset Alzheimer’s disease
    Song Gao, Aaron Casey, Timothy J. Sargeant, Ville‐Petteri Mäkinen · 2018 · Brain
27. A potential endophenotype for Alzheimer's disease: cerebrospinal fluid clusterin
    Deming, Yuetiva, Xia, Jian, Cai, Yefei, Lord, Jenny, Holmans, Peter, Bertelsen, Sarah, Holtzman, David, Morris, John C., Bales, Kelly, Pickering, Eve H. et al. · 2016 · Neurobiology of Aging
28. Deleterious ABCA7 mutations and transcript rescue mechanisms in early onset Alzheimer’s disease
    On behalf of the European Early-Onset Dementia (EU EOD) consortium, De Roeck, Arne, Van den Bossche, Tobi, van der Zee, Julie, Verheijen, Jan, De Coster, Wouter, Van Dongen, Jasper, Dillen, Lubina, Baradaran-Heravi, Yalda, Heeman, Bavo et al. · 2017 · Acta Neuropathologica
29. Genetics of vascular dementia – review from the ICVD working group
    M. Arfan Ikram, Anna Bersano, Raquel Manso-Calderón, Jianping Jia, Helena Schmidt, Lefkos T. Middleton, Benedetta Nacmias, Saima Siddiqi, Hieab H.H. Adams · 2017 · BMC Medicine
30. Susceptibility to neurofibrillary tangles: role of the PTPRD locus and limited pleiotropy with other neuropathologies
    Lori Beth Chibnik, Charles C. White, Shubhabrata Mukherjee, Towfique Raj, Lei Yu, Eric Berg Larson, Thomas Jude Montine, Christopher Dirk Keene, Joshua Aaron Sonnen, Julie A. Schneider et al. · 2017 · Molecular Psychiatry
31. ABCA1- and ABCG1-mediated cholesterol efflux capacity of cerebrospinal fluid is impaired in Alzheimer's disease
    Cinzia Marchi, Maria Pia Adorni, Paolo Caffarra, Nicoletta Ronda, Marco Spallazzi, Federica Barocco, Daniela Galimberti, Franco Bernini, Francesca Zimetti · 2019 · Journal of Lipid Research
32. Neuroinflammatory Signaling in the Pathogenesis of Alzheimer’s Disease
    Md. Sahab Uddin, Md. Tanvir Kabir, Maroua Jalouli, Md. Ataur Rahman, Philippe Jeandet, Tapan Behl, Athanasios T. Alexiou, Ghadeer Mohsen Albadrani, Mohamed M. Abdel‐Daim, Asma Perveen et al. · 2021 · Current Neuropharmacology
33. Branched-chain amino acids and Alzheimer’s disease: a Mendelian randomization analysis
    Susanna C. Larsson, Hugh Stephen Markus · 2017 · Scientific Reports
34. Signaling Mechanisms of Selective PPARγ Modulators in Alzheimer’s Disease
    Manoj Govindarajulu, Priyanka D. Pinky, Jenna Bloemer, Nila Ghanei, Vishnu D. Suppiramaniam, Rajesh Amin · 2018 · PPAR Research
35. Integrative genomics approach identifies conserved transcriptomic networks in Alzheimer’s disease
    Morabito, Samuel, Miyoshi, Emily, Michael, Neethu, Swarup, Vivek · 2020 · Human Molecular Genetics
36. Molecular Genetics of Neurodegenerative Dementias
    Flora I. Hinz, Daniel H. Geschwind · 2016 · Cold Spring Harbor Perspectives in Biology
37. Impact of cardiovascular risk factors and genetics on 10-year absolute risk of dementia: risk charts for targeted prevention
    Juul Rasmussen, Ida, Rasmussen, Katrine Laura, Nordestgaard, Børge G, Tybjærg-Hansen, Anne, Frikke-Schmidt, Ruth · 2020 · European Heart Journal
38. Genetic study of multimodal imaging Alzheimer’s disease progression score implicates novel loci
    Scelsi, Marzia A, Khan, Raiyan R, Lorenzi, Marco, Christopher, Leigh, Greicius, Michael D, Schott, Jonathan M, Ourselin, Sebastien, Altmann, Andre · 2018 · Brain
39. Shifting equilibriums in Alzheimer’s disease: the complex roles of microglia in neuroinflammation, neuronal survival and neurogenesis
    Sophie Gray, K. J. Kinghorn, Nathaniel S. Woodling · 2020 · Neural Regeneration Research
40. Genomics and Functional Genomics of Alzheimer's Disease
    Kamboh, M. Ilyas · 2022 · Neurotherapeutics
41. Clinical utility of polygenic risk scores: a critical 2023 appraisal
    Sebastian Koch, Jörg Schmidtke, Michael Krawczak, Amke Caliebe · 2023 · Journal of Community Genetics
42. Single-cell analysis reveals inflammatory interactions driving macular degeneration
    Manik Razdan Kuchroo, Marcello DiStasio, Eric Song, Eda Calapkulu, Le Zhang, Maryam Ige, Amar H. Sheth, Abdelilah Majdoubi, Madhvi Menon, Alexander Tong et al. · 2023 · Nature Communications
43. Alzheimer’s Disease Diagnosis Using Machine Learning: A Survey
    Omer Asghar Dara, José Manuel López-Guede, Hasan Issa Raheem, Javad Rahebi, Ekaitz Zulueta, Unai Fernández‐Gámiz · 2023 · Applied Sciences
44. Current views on meningeal lymphatics and immunity in aging and Alzheimer’s disease
    Shanon Rego, Guadalupe Sánchez, Sandro Dá Mesquita · 2023 · Molecular Neurodegeneration
45. Late-onset Alzheimer disease risk variants mark brain regulatory loci
    Allen, Mariet, Kachadoorian, Michaela, Carrasquillo, Minerva M., Karhade, Aditya, Manly, Lester, Burgess, Jeremy D., Wang, Chen, Serie, Daniel, Wang, Xue, Siuda, Joanna et al. · 2015 · Neurology Genetics
46. 5-Hydroxymethylation-associated epigenetic modifiers of Alzheimer’s disease modulate Tau-induced neurotoxicity
    Alison I. Bernstein, Yunting Lin, R. Craig Street, Li Lin, Qing Dai, Li Yu, Han Bao, Marla Gearing, James J. Lah, Peter T. Nelson et al. · 2016 · Human Molecular Genetics
47. HOPS: a quantitative score reveals pervasive horizontal pleiotropy in human genetic variation is driven by extreme polygenicity of human traits and diseases
    Jordan, Daniel M., Verbanck, Marie, Do, Ron · 2019 · Genome Biology
48. Microglial repopulation reverses cognitive and synaptic deficits in an Alzheimer’s disease model by restoring BDNF signaling
    Wang, Wanbing, Li, Yanzhong, Ma, Fangling, Sheng, Xuan, Chen, Kai, Zhuo, Rengong, Wang, Chen, Zheng, Honghua, Zhang, Yun-wu, Bu, Guojun et al. · 2023 · Brain, Behavior, and Immunity
49. Genetic risk variants for social anxiety
    Stein, Murray B., Chen, Chia‐Yen, Jain, Sonia, Jensen, Kevin P., He, Feng, Heeringa, Steven G., Kessler, Ronald C., Maihofer, Adam, Nock, Matthew K., Ripke, Stephan et al. · 2017 · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
50. Toward stem cell-based phenotypic screens for neurodegenerative diseases
    Vikram Khurana, Daniel F. Tardiff, Chee Yeun Chung, Susan Lee Lindquist · 2015 · Nature Reviews Neurology
51. Biological Hallmarks of Cancer in Alzheimer’s Disease
    Kelly Nicole Holohan Nudelman, Brenna C. McDonald, Debomoy K. Lahiri, Andrew J. Saykin · 2019 · Molecular Neurobiology
52. Impaired β-glucocerebrosidase activity and processing in frontotemporal dementia due to progranulin mutations
    Andrew E. Arrant, Jonathan R. Roth, Nicholas R. Boyle, Shreya N. Kashyap, Madelyn Q. Hoffmann, Charles Murchison, Eliana Marisa Ramos, Alissa L. Nana, Salvatore Spina, Lea T. Grinberg et al. · 2019 · Acta Neuropathologica Communications
53. Shared genetic etiology underlying Alzheimer’s disease and major depressive disorder
    Michael William Lutz, Daniel Sprague, Julio Barrera, Ornit Chiba‐Falek · 2020 · Translational Psychiatry
54. HDL Cholesterol and Non-Cardiovascular Disease: A Narrative Review
    Emilie Westerlin Kjeldsen, Liv Tybjærg Nordestgaard, Ruth Frikke‐Schmidt · 2021 · International Journal of Molecular Sciences
55. CFH Variants Affect Structural and Functional Brain Changes and Genetic Risk of Alzheimer’s Disease
    Alzheimer’s Disease Neuroimaging Initiative, Dengfeng Zhang, Jin Li, Huan Wu, Yue Julia Cui, Rui Bi, Hejiang Zhou, Hui-Zhen Wang, Chen Zhang, Dong Wang et al. · 2015 · Neuropsychopharmacology
56. The Alu neurodegeneration hypothesis: A primate‐specific mechanism for neuronal transcription noise, mitochondrial dysfunction, and manifestation of neurodegenerative disease
    Peter A. Larsen, Michael William Lutz, Kelsie E. Hunnicutt, Mirta Mihovilovic, Ann M. Saunders, Anne D. Yoder, Allen D. Roses · 2017 · Alzheimer s & Dementia
57. Genome‐wide association study of Alzheimer's disease endophenotypes at prediagnosis stages
    Chung, Jaeyoon, Wang, Xulong, Maruyama, Toru, Ma, Yiyi, Zhang, Xiaoling, Mez, Jesse, Sherva, Richard, Takeyama, Haruko, The Alzheimer's Disease Neuroimaging Initiative, Lunetta, Kathryn L. et al. · 2018 · Alzheimer's &amp; Dementia
58. The role of the immune system in driving neuroinflammation
    Ní Chasaide, Caitlín, Lynch, Marina A · 2020 · Brain and Neuroscience Advances
59. Microfluidic isoform sequencing shows widespread splicing coordination in the human transcriptome
    Tilgner, Hagen, Jahanbani, Fereshteh, Gupta, Ishaan, Collier, Paul, Wei, Eric, Rasmussen, Morten, Snyder, Michael · 2018 · Genome Research
60. Benchmarking machine learning models for late-onset alzheimer’s disease prediction from genomic data
    De Velasco Oriol, Javier, Vallejo, Edgar E., Estrada, Karol, Taméz Peña, José Gerardo, Disease Neuroimaging Initiative, The Alzheimer’s · 2019 · BMC Bioinformatics
61. Relation of genomic variants for Alzheimer disease dementia to common neuropathologies
    Farfel, Jose M., Yu, Lei, Buchman, Aron S., Schneider, Julie A., De Jager, Philip L., Bennett, David A. · 2016 · Neurology
62. Flow-cytometric microglial sorting coupled with quantitative proteomics identifies moesin as a highly-abundant microglial protein with relevance to Alzheimer’s disease
    Rayaprolu, Sruti, Gao, Tianwen, Xiao, Hailian, Ramesha, Supriya, Weinstock, Laura D., Shah, Jheel, Duong, Duc M., Dammer, Eric B., Webster, James A., Lah, James J. et al. · 2019
63. Genetic variants near MLST8 and DHX57 affect the epigenetic age of the cerebellum
    Ake Tzu-Hui Lu, Eilis J. Hannon, Morgan E. Levine, Ke Hao, Eileen M. Crimmins, Katie Lunnon, Alexey Kozlenkov, Jonathan S. Mill, Stella M. Dracheva, Steve Horvath · 2016 · Nature Communications
64. Polygenic Risk Scores in Alzheimer's Disease: Current Applications and Future Directions
    2020
65. Genome-wide association study of Alzheimer’s disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset
    Shengjun Hong, Dmitry Prokopenko, Valerija Dobričić, Fabian Kilpert, Isabelle Bos, Stephanie J. B. Vos, Betty Marije Tijms, Ulf Andréasson, Kaj Blennow, Rik R. Vandenberghe et al. · 2020 · Translational Psychiatry
66. Associations of Alzheimer’s disease risk variants with gene expression, amyloidosis, tauopathy, and neurodegeneration
    Alzheimer’s Disease Neuroimaging Initiative, Tan, Meng-Shan, Yang, Yu-Xiang, Xu, Wei, Wang, Hui-Fu, Tan, Lin, Zuo, Chuan-Tao, Dong, Qiang, Tan, Lan, Suckling, John et al. · 2021 · Alzheimer's Research &amp; Therapy
67. Human iPSC-derived astrocytes transplanted into the mouse brain undergo morphological changes in response to amyloid-β plaques
    Pranav Preman, Julia TCW, Sara Calafate, An Snellinx, María Alfonso-Triguero, Nikky Corthout, Sebastian Munck, Dietmar Rudolf Thal, Alison Goate, Bart De Strooper et al. · 2021 · Molecular Neurodegeneration
68. Single-cell RNA transcriptome analysis of CNS immune cells reveals CXCL16/CXCR6 as maintenance factors for tissue-resident T cells that drive synapse elimination
    Sarah F. Rosen, Allison Soung, Wei Yang, Shenjian Ai, Marlene Kanmogne, Veronica A. Davé, Sairam Prabhakar, Amanda Swain, Maxim N. Artyomov, Jeffrey A. Magee et al. · 2022 · Genome Medicine
69. F‐box/ LRR ‐repeat protein 7 is genetically associated with Alzheimer's disease
    Giuseppe Tosto, Hongjun Fu, Badri Narayan Vardarajan, Joseph Hyungwoo Lee, Rong Cheng, Dolly Reyes‐Dumeyer, Rafael Lantigua, Martin Z. Medrano, Ivonne Z. Jiménez‐Velázquez, Mitchell S.V. Elkind et al. · 2015 · Annals of Clinical and Translational Neurology
70. Gene expression and functional annotation of human choroid plexus epithelium failure in Alzheimer’s disease
    The Netherlands Brain Bank, Arthur A B Bergen, Sovann Kaing, Jacoline B. ten Brink, Theo G. M. F. Gorgels, Sarah F. Janssen · 2015 · BMC Genomics
71. Using an Alzheimer Disease Polygenic Risk Score to Predict Memory Decline in Black and White Americans Over 14 Years of Follow-up
    Jessica R. Marden, Elizabeth Rose Mayeda, Stefan Walter, Alexandre Vivot, Eric J. Tchetgen Tchetgen, Ichiro I. Kawachi, M. Maria Glymour · 2016 · Alzheimer Disease & Associated Disorders
72. Polygenic Risk Score for Alzheimer’s Disease: Implications for Memory Performance and Hippocampal Volumes in Early Life
    Luiza Kvitko Axelrud, Marcos Leite Santoro, Daniel S. Pine, Fernanda Talarico, Ary Gadelha, Gisele Gus Manfro, Pedro Mário Pan, Andrea Parolin Jackowski, Felipe Almeida Picon, Elisa Macedo Brietzke et al. · 2018 · American Journal of Psychiatry
73. The causes and consequences of Alzheimer's disease: phenome-wide evidence from mendelian randomization
    Korologou-Linden, Roxanna, Bhatta, Laxmi, Brumpton, Ben M., Howe, Laura D., Millard, Louise A. C., Kolaric, Katarina, Ben-Shlomo, Yoav, Williams, Dylan M., Smith, George Davey, Anderson, Emma L. et al. · 2022 · Nature Communications
74. <scp><i>PLXNA</i></scp><i>4</i> is associated with <scp>A</scp>lzheimer disease and modulates tau phosphorylation
    Jun, Gyungah, Asai, Hirohide, Zeldich, Ella, Drapeau, Elodie, Chen, CiDi, Chung, Jaeyoon, Park, Jong‐Ho, Kim, Sehwa, Haroutunian, Vahram, Foroud, Tatiana et al. · 2014 · Annals of Neurology
75. The Medical Genome Reference Bank contains whole genome and phenotype data of 2570 healthy elderly
    Pinese, Mark, Lacaze, Paul, Rath, Emma M., Stone, Andrew, Brion, Marie-Jo, Ameur, Adam, Nagpal, Sini, Puttick, Clare, Husson, Shane, Degrave, Dmitry et al. · 2020 · Nature Communications
76. Alzheimer’s disease risk gene BIN1 induces Tau-dependent network hyperexcitability
    Yuliya Voskobiynyk, Jonathan R. Roth, J. Nicholas Cochran, Travis Rush, Nancy V. N. Carullo, Jacob S Mesina, Mohammad Waqas, Rachael M. Vollmer, Jeremy J. Day, Lori L. McMahon et al. · 2020 · eLife
77. Multi-omic comparison of Alzheimer’s variants in human ESC–derived microglia reveals convergence at APOE
    Tong‐Fei Liu, Bing Zhu, Yan Liu, Xiaoming Zhang, Jun Yin, Xiaoguang Li, Lu-Lin Jiang, Andrew P. Hodges, Sara Brin Rosenthal, Lisa Zhou et al. · 2020 · The Journal of Experimental Medicine
78. TREM2 Mediates Microglial Anti-Inflammatory Activations in Alzheimer’s Disease: Lessons Learned from Transcriptomics
    Feng Xue, Heng Du · 2021 · Cells
79. A transcriptome-wide association study of Alzheimer’s disease using prediction models of relevant tissues identifies novel candidate susceptibility genes
    Yanfa Sun, Jingjing Zhu, Dan Zhou, Saranya Canchi, Chong Wu, Nancy Jean Cox, Robert A. Rissman, Eric R. Gamazon, Lang Wu · 2021 · Genome Medicine
80. Physical and Mental Activity, Disease Susceptibility, and Risk of Dementia
    Jianwei Zhu, Fenfen Ge, Yu Zeng, Yuanyuan Qu, Wenwen Chen, Huazhen Yang, Lei Yang, Fang Fang, Huan Song · 2022 · Neurology
81. CD33 isoforms in microglia and Alzheimer's disease: Friend and foe
    Ghazaleh Eskandari‐Sedighi, Jaesoo Jung, Matthew Scott Macauley · 2022 · Molecular Aspects of Medicine
82. Complement C3aR depletion reverses HIF-1α–induced metabolic impairment and enhances microglial response to Aβ pathology
    Manasee Gedam, Michele M. Comerota, Nicholas E. Propson, Tao Chen, Feng Jin, Meng Carla Wang, Hui Zheng · 2023 · Journal of Clinical Investigation
83. The VCAM1–ApoE pathway directs microglial chemotaxis and alleviates Alzheimer’s disease pathology
    Lau, Shun-Fat, Wu, Wei, Wong, Hiu Yi, Ouyang, Li, Qiao, Yi, Xu, Jiahui, Lau, Jessica Hiu-Yan, Wong, Carlton, Jiang, Yuanbing, Holtzman, David M. et al. · 2023 · Nature Aging
84. Dissecting Complex and Multifactorial Nature of Alzheimer’s Disease Pathogenesis: a Clinical, Genomic, and Systems Biology Perspective
    Puneet Talwar, Juhi Sinha, Sandeep Grover, Chitra Rawat, Suman S. Kushwaha, Rachna Agarwal, Vibha Taneja, Ritushree Kukreti · 2015 · Molecular Neurobiology
85. How strong is the relationship between glaucoma, the retinal nerve fibre layer, and neurodegenerative diseases such as Alzheimer’s disease and multiple sclerosis?
    Eneh Jones-Odeh, Christopher J. Hammond · 2015 · Eye
86. Alzheimer's Disease prevalence, costs, and prevention for military personnel and veterans
    Leslie Sibener, Ibrahim Zaganjor, Heather M. Snyder, Lisa J. Bain, Robert Egge, María C. Carrillo · 2014 · Alzheimer s & Dementia
87. Validating GWAS-Identified Risk Loci for Alzheimer’s Disease in Han Chinese Populations
    Hui-Zhen Wang, Rui Bi, Qiu-Xiang Hu, Qun Xiang, Chen Zhang, Dengfeng Zhang, Wen Zhang, Xiaohong Ma, Wanjun Guo, Wei Deng et al. · 2014 · Molecular Neurobiology
88. Reassessment of Risk Genotypes (GRN,TMEM106B, andABCC9Variants) Associated With Hippocampal Sclerosis of Aging Pathology
    Peter T. Nelson, Wang‐Xia Wang, Amanda B. Partch, Sarah E. Monsell, Otto Valladares, Sally R. Ellingson, Bernard R. Wilfred, Adam Christian Naj, Li-San Wang, Walter A. Kukull et al. · 2014 · Journal of Neuropathology & Experimental Neurology
89. Understanding the genetics of <i>APOE</i> and <i>TOMM40</i> and role of mitochondrial structure and function in clinical pharmacology of Alzheimer's disease
    Roses, Allen, Sundseth, Scott, Saunders, Ann, Gottschalk, William, Burns, Dan, Lutz, Michael · 2016 · Alzheimer's &amp; Dementia
90. A state of delirium: Deciphering the effect of inflammation on tau pathology in Alzheimer's disease
    Matthew Barron, Jane E. Gartlon, Lee A. Dawson, Peter J. Atkinson, Marie‐Christine Pardon · 2016 · Experimental Gerontology
91. Incidence of cognitively defined late‐onset Alzheimer's dementia subgroups from a prospective cohort study
    Paul K. Crane, Emily H. Trittschuh, Shubhabrata Mukherjee, Andrew J. Saykin, Ruth Elizabeth Sanders, Eric Berg Larson, Susan M. McCurry, Wayne C. McCormick, James D. Bowen, Thomas J. Grabowski et al. · 2017 · Alzheimer s & Dementia
92. Genome-wide association study of brain amyloid deposition as measured by Pittsburgh Compound-B (PiB)-PET imaging
    for the Alzheimer’s Disease Neuroimaging Initiative (ADNI), Yan, Qi, Nho, Kwangsik, Del-Aguila, Jorge L., Wang, Xingbin, Risacher, Shannon L., Fan, Kang-Hsien, Snitz, Beth E., Aizenstein, Howard J., Mathis, Chester A. et al. · 2021 · Molecular Psychiatry
93. Reactive astrocytes as treatment targets in Alzheimer's disease—Systematic review of studies using the <scp>APPswePS1dE9</scp> mouse model
    Smit, Tamar, Deshayes, Natasja A. C., Borchelt, David R., Kamphuis, Willem, Middeldorp, Jinte, Hol, Elly M. · 2021 · Glia
94. Lack of Genetic Association Between <i>TREM2</i> and Late-Onset Alzheimer's Disease in a Japanese Population
    Miyashita, Akinori, Wen, Yanan, Kitamura, Nobutaka, Matsubara, Etsuro, Kawarabayashi, Takeshi, Shoji, Mikio, Tomita, Naoki, Furukawa, Katsutoshi, Arai, Hiroyuki, Asada, Takashi et al. · 2014 · Journal of Alzheimer’s Disease
95. Pathway-based discovery of genetic interactions in breast cancer
    Wen Wang, Zack Xu, Michael Costanzo, Charles M. Boone, Carol Ann Lange, Chad L. Myers · 2017 · PLoS Genetics
96. Cortical microstructural correlates of astrocytosis in autosomal-dominant Alzheimer disease
    Eduard Vilaplana, Elena Rodriguez‐Vieitez, Daniel Ferreira, Víctor Montal, Ove Almkvist, Anders E. Wall, Alberto Lleó, Eric Westman, Caroline Graff, Juan Fortea et al. · 2020 · Neurology
97. Sex-dependent autosomal effects on clinical progression of Alzheimer’s disease
    Chun Chieh Fan, Sarah Jane Banks, Wesley Kurt Thompson, Chi‐Hua Chen, Linda K. McEvoy, Chin Hong Tan, Walter A. Kukull, David A. A Bennett, Lindsay A. Farrer, Richard P Mayeux et al. · 2020 · Brain
98. Bacterial Extracellular Vesicles and the Gut‐Microbiota Brain Axis: Emerging Roles in Communication and Potential as Therapeutics
    Nicholas H. Pirolli, William E. Bentley, Steven M. Jay · 2021 · Advanced Biology
99. S-Nitrosylation-Mediated Redox Transcriptional Switch Modulates Neurogenesis and Neuronal Cell Death
    Shu‐ichi Okamoto, Tomohiro Nakamura, Piotr Cieplak, Shing Fai Chan, Evgenia Kalashnikova, Lujian Liao, Sofiyan Saleem, Xuemei Han, Arjay Clemente, Anthony Nutter et al. · 2014 · Cell Reports
100. Level of PICALM, a key component of clathrin-mediated endocytosis, is correlated with levels of phosphotau and autophagy-related proteins and is associated with tau inclusions in AD, PSP and Pick disease
     Kunié Ando, Karen Tomimura, Véronique Sazdovitch, Valérie Suain, Zehra Yilmaz, Michèle Authelet, Marième Ndjim, Cristina Vergara, Mounir Belkouch, Marie‐Claude Potier et al. · 2016 · Neurobiology of Disease